Skip to main content
OpenTrials
Completed

NCT Number: NCT07139080

Effect of Mobile Application-Based Education on Self-Efficacy, Medication Adherence and Sleep Quality in Asthma.

Asthma patients with recurrent airway obstruction frequently exhibit poor symptom control, characterized by treatment non-adherence and sleep-wake cycle disturbances. A nurse-led mobile health education intervention may address these challenges by enhancing collaborative disease management, enabling remote patient monitoring, and strengthening self-management competencies.

The AstımAsistan application was designed to monitor changes in patient self-efficacy, medication adherence, and sleep quality through three core features: (1) patient education modules, (2) breathing exercise/medication reminders, and (3) mobile consultation capabilities.

Study data were collected using four instruments: (1) the Participant Information Form, (2) the Chronic Disease Self-Efficacy Scale, (3) the Medication Adherence Reporting Scale, and (4) the Pittsburgh Sleep Quality Index. The mobile education-based application was developed following the ADDIE (Analysis, Design, Development, Implementation, and Evaluation) instructional design model."

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Patient Education Asthma Behavior Bronchial Diseases Health Behavior Hypersensitivity Hypersensitivity, Immediate Immune System Diseases Lung Diseases Lung Diseases, Obstructive Medication Adherence Patient Acceptance of Health Care Patient Compliance Respiratory Hypersensitivity Respiratory Tract Diseases Treatment Adherence and Compliance

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Gulhane Training and Research Hospital

Ankara, KEÇİÖREN, 06010, Turkey (Türkiye)

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Being between the ages of 18-65
  • Having been diagnosed with asthma at least 6 months ago
  • Being treated for asthma in oral, inhaler or injection forms
  • Being literate in Turkish
  • Having an Android phone on which the mobile application can be installed and being able to use the phone
  • Having mobile network or wireless internet access
  • Volunteering to participate in research
  • Living in Ankara

Exclusion criteria

  • Being hospitalized for asthma treatment
  • Having a language barrier that hinders communication
  • Being diagnosed with COPD
  • Being diagnosed with a psychiatric disease
  • Being on psychoactive or opioid therapy
  • Being diagnosed with a sleep disorder related to non-respiratory reasons (physical and psychological) and being treated

Exclusion criteria

when the study is going on :

Intervention group;

  • The participant was diagnosed with a health problem requiring inpatient treatment during the study period.
  • The participant withdraws from the study voluntarily.
  • Inability to use the mobile application during the research
  • Reading fewer than 6 theme headings in the mobile application (75% or less) and missing breathing exercises for more than 16 days (80% or less)

Control group;

  • The participant was diagnosed with a health problem requiring inpatient treatment during the study period.
  • The participant withdraws from the study voluntarily.

Treatment and study plan

Mobile education

Behavioral

It consists of participants who will download the mobile patient education and breathing exercise reminder program and apply it for 10 weeks.

Primary outcomes

  1. Chronic Disease Self-Efficacy

    Time frame: 10 weeks

    Chronic Disease Self Efficacy Scale: In this 30-item scale, each question is scored between 1 and 10 points to determine the level of self-efficacy. The total score obtained by the individual from the scale is divided by the number of items to calculate an overall self-efficacy average. The scale also has 10 subtitles. If the 30 items' average is below 7, it means the individual has low self-efficacy. If the average is 7 or above, it indicates that the individual has high self-efficacy regarding their illness and believes they can achieve their goals."

  2. Medication Adherence

    Time frame: 10 weeks

    The Medication Adherence Report Scale (MARS), developed by Horne and Hankins (2001), can be adapted based on disease type. The scale requires participants to indicate the frequency of occurrence for 5 specific statements in themselves. The scoring uses a Likert-type scale where: 5=never, 4=rarely, 3=sometimes, 2=often, and 1=always. The total test score is obtained by summing the scores from all items. The minimum possible score on the scale is 5, and the maximum is 25. Higher scores indicate compliance, while lower scores suggest non-compliance.

  3. Sleep Quality

    Time frame: 10 weeks

    PSQI is developed by Buysse et al. in 1989, this scale is used to assess sleep quality and identify factors contributing to sleep disorders. Its validity and reliability for our country were established by Ağargün et al. The scale consists of 18 scored items grouped into 7 component scores, with each item rated on a 0-3 scale. The components are:

    Subjective Sleep Quality Sleep Latency Sleep Duration Habitual Sleep Efficiency Sleep Disturbances Use of Sleep Medication Daytime Dysfunction

    The total scale score is calculated by summing the seven component scores. A total score of 5 or higher indicates poor sleep quality.

Sponsors and collaborators

Lead sponsor

Gulhane Training and Research Hospital

Other Gov

Registry information

Official study title

The Effect of Mobile Application-Based Education on Self-Efficacy, Medication Adherence and Sleep Quality in Asthma Patients.

Important dates

Study start
2023
Primary completion
2025
Study completion
2025
First posted
Aug 24, 2025
Registry last updated
Aug 24, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.